Andrew Brack

Andrew Brack, Ph.D.

Program Manager, Proactive Health

Andrew Brack joined ARPA-H in April 2024 from the University of California San Francisco’s Department of Orthopaedic Surgery. For 16 years, his lab studied the cellular and molecular mechanisms that regulate skeletal muscle repair during aging. He was the co-founder of Arrive Bio, a longevity company that uses machine learning to identify drugs to treat age-related diseases.  

Brack received a Ph.D. in molecular biology and biophysics from King’s College London and completed two postdoctoral fellowships, one at King’s College London and the second at Stanford University. Throughout his career Brack has led multidisciplinary teams with the goal of restoring healthy function during aging.